23 results
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
of such Person under swaps, options, derivatives and other hedging agreements or arrangements that will be payable upon termination thereof (assuming
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
owned Parent Subsidiary), or (vi) net cash payment obligations of such Person under swaps, options, derivatives and other hedging agreements
424B4
agw4y1 n35
1 Apr 21
Prospectus supplement with pricing info
4:05pm
10-K
qln0513cnchh64sfel33
19 Mar 21
Annual report
4:11pm
DRS
uirkd24gkdosvqzq
19 Mar 21
Draft registration statement
12:00am
8-K
EX-3.2
072bnkbdx1bo7y 6m
9 Jun 20
Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
4:47pm
424B4
e74fd
5 Jun 20
Prospectus supplement with pricing info
4:52pm
S-1
EX-10.3
p5qsmo5 8zmhu4m
18 May 20
IPO registration
4:03pm
S-1
mwvdd
18 May 20
IPO registration
4:03pm
S-1
EX-3.4
ov1h2y8kkgx aqgjet53
18 May 20
IPO registration
4:03pm
S-1
EX-10.2
h5efetfd 3z
18 May 20
IPO registration
4:03pm
S-1
EX-4.1
iwc1uc84ji5bm8zxrv3h
18 May 20
IPO registration
4:03pm
DRS/A
2anxnsykq5qykzkhqrwf
10 Apr 20
Draft registration statement (amended)
12:00am
DRS
EX-10.2
tckn xl41u9gev3aix
13 Feb 20
Draft registration statement
12:00am